| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
|
Nomura, Hisanaga
|
|
|
86 |
2 |
p. 315-324
|
artikel
|
| 2 |
Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells
|
Reddy, R. Gajendra
|
|
|
86 |
2 |
p. 165-179
|
artikel
|
| 3 |
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401)
|
Samura, Hironori
|
|
|
86 |
2 |
p. 285-294
|
artikel
|
| 4 |
A phase Ι study to evaluate the application of photocyanine using pharmacokinetic and pharmacodynamic analysis in patients with malignancy
|
Li, Su
|
|
|
86 |
2 |
p. 267-276
|
artikel
|
| 5 |
A randomized, double-blind, parallel-group, single‑dose, pharmacokinetic bioequivalence study of INTP24 and bevacizumab in healthy adult men
|
Singh, Inderjeet
|
|
|
86 |
2 |
p. 193-202
|
artikel
|
| 6 |
Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration
|
Uchino, Tomonobu
|
|
|
86 |
2 |
p. 233-243
|
artikel
|
| 7 |
Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells
|
Zhang, Hui
|
|
|
86 |
2 |
p. 257-266
|
artikel
|
| 8 |
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study
|
Kan, Motoyasu
|
|
|
86 |
2 |
p. 203-210
|
artikel
|
| 9 |
Cytotoxic and biomechanical effects of clinical dosing schemes of paclitaxel on neurons and cancer cells
|
Lin, Chou-Ching K.
|
|
|
86 |
2 |
p. 245-255
|
artikel
|
| 10 |
Excretion balance and pharmacokinetics following a single oral dose of [14C]-fedratinib in healthy subjects
|
Ogasawara, Ken
|
|
|
86 |
2 |
p. 307-314
|
artikel
|
| 11 |
HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer
|
Jiang, Jiahong
|
|
|
86 |
2 |
p. 295-305
|
artikel
|
| 12 |
Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer
|
Wang, Fang-Tao
|
|
|
86 |
2 |
p. 221-232
|
artikel
|
| 13 |
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
|
Kito, Yosuke
|
|
|
86 |
2 |
p. 277-284
|
artikel
|
| 14 |
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer
|
Shimizu, Toshio
|
|
|
86 |
2 |
p. 211-219
|
artikel
|
| 15 |
Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors
|
Wang, Erjian
|
|
|
86 |
2 |
p. 181-192
|
artikel
|
Tijdschrift beschrijving